Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Helicos BioSciences Corp.

www.helicosbio.com

Latest From Helicos BioSciences Corp.

Molecular Diagnostics Ushers In New Era Of Prenatal Testing

The recent launch of several noninvasive gene-based tests for Down syndrome and other fetal chromosomal abnormalities is poised to upend current prenatal screening practices and potentially usher in a new, multibillion-dollar market opportunity in the process. These new tests employ next-generation gene sequencing, along with advanced, risk-based computer algorithms, to detect and characterize fetal genetic abnormalities using the DNA present in a maternal blood sample. And because they are actually able to “interrogate” the DNA, they represent a huge technological advance over the current standard-of-care for prenatal screening.

Medical Device Legal Issues

Deals in Depth: April 2012

Forest paid Janssen $357 million to acquire US and Canadian IP related to Bystolic. Nestle bought Pfizer’s nutritional’s business and Hologic beefed up its women’s health portfolio through its $3.8 billion Gen-Probe takeover. Both biopharma and medical device financing were down in April compared with last month.

BioPharmaceutical Medical Device

Medical Device Deals Update, May 2012

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.

Medical Device

Deals Shaping The Medical Industry, May 2012

The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Helicos BioSciences Corp.
  • Senior Management
  • Ivan Trifunovich, PhD, Pres. & CEO
    Jeffrey R Moore, SVP, CFO
  • Contact Info
  • Helicos BioSciences Corp.
    Phone: (617) 264-1800
    One Kendall Sq.
    Ste. 7301
    Cambridge, MA 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register